Key result
The DREAMER score, incorporating six clinical risk factors, predicted 30-day emergency department revisits for drug-related problems with an AUROC of 0.71 in the validation cohort.
Why the study?
Drug-related problems frequently cause ED visits, but data on the risk factors associated with 30-day ED revisits are limited.
Can the DREAMER score predict the risk of emergency department revisits within 30 days in patients presenting with cardiovascular drug-related problems?
Cohort (n=581)
No
Can the DREAMER score predict the risk of emergency department revisits within 30 days in patients presenting with cardiovascular drug-related problems?
The DREAMER score is a validated tool that identifies patients at high risk for 30-day ED revisits after presenting with cardiovascular drug-related problems, aiding in discharge prioritization.
Answers are grounded in this paper and cite their sources.
May guide targeted follow-up after cardiovascular drug-related ED visits; hypothesis-generating until prospective trials assess outcome impact.
Background: Drug-related problems (DRPs) are a frequent reason for emergency departments (EDs) visits. However, data about the risk factors associated with EDs revisits are limited. Objective: To develop and validate a predictive model indicating the risk factors associated with EDs revisit within 30 days of the first visit. Methods: A retrospective cohort study was conducted involving patients who attended an ED for DRPs related to cardiovascular drugs. A 30-day prediction model was created in a derivation cohort by logistic regression. An integer score proportional to the regression coefficient was assigned to the variables with P < .100 in the multivariate analysis. Results: 581 patients (mean age: 80.0 [12.6] years) were included, 133 (22.9%) revisited the ED within 30 days from discharge. Six factors (chronic kidney disease, chronic heart failure, visit to an ED in the preceding 3 months, high anticholinergic burden, DRPs associated with heparin, and safety-related DRPs) were identified as risk factors and combined into a final score, termed the DREAMER score. The model reached an area under the receiver operating curve values of 0.72 (95% confidence interval [CI] = 0.67-0.77) in the referral cohort and 0.71 (95% CI = 0.65-0.74) in the validation cohort ( P = .273). Three risk categories were generated, with the following scores and estimated risks: low risk (0-8 points): 11.6%; intermediate risk (9-14 points): 21.3%; and high risk (>14 points): 41.2%. Conclusion and Relevance: The DREAMER score identifies patients at high risk for ED revisit within 30 days from the first visit for a DRPs, being a useful tool to prioritize interventions on discharge.
No takes yet. Share an insight, caveat, or question.
Gras-Martín et al. (2021) conducted a cohort in Drug-related problems (DRPs) (n=581). DREAMER score (risk factors for ED revisit) was evaluated on Predictive accuracy of the DREAMER score for ED revisit within 30 days (AUROC 0.71, 95% CI 0.65-0.74, p=0.273). The DREAMER score, incorporating six clinical risk factors, predicted 30-day emergency department revisits for drug-related problems with an AUROC of 0.71 in the validation cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: